6 months ago
XERS
AnalystsBrandon FolkesBrandon Folkes's Stock Forecasts
AnalystsBrandon Folkes
Analyst Ranking
Bottom 13%
#4559 out of 5186 analysts
Average Return
-0.49%
Win Rate
45%47 out of 104
Risk vs Reward
Poor
Good
Brandon Folkes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Connect Biopharma Holdings LtdCNTB | +189.41% | $0.85 | $2.46 | 2025-06-11 - 2026-02-02 | Buy |
Elutia IncELUT | +130.77% | $1.43 | $3.30 | 2023-08-14 - 2024-08-14 | Strong Buy |
Trevi Therapeutics IncTRVI | +122.74% | $2.77 | $6.17 | 2024-06-12 - 2025-06-12 | Strong Buy |
Cormedix IncCRMD | +118.98% | $6.27 | $13.73 | 2024-08-25 - 2025-08-25 | Strong Buy |
Eupraxia Pharmaceuticals IncEPRX | +94.81% | $4.62 | $9.00 | 2025-06-25 - 2026-01-23 | Buy |
Brandon Folkes Analyst Color
Get additional color on Brandon Folkes's coverage of popular stocks
Brandon Folkes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mannkind CorpMNKD | 7 | Buy | $11.00 | +83.03% | Reiterates | 8 days ago |
Cormedix IncCRMD | 5 | Buy | $13.00 | +59.12% | Maintains | 11 days ago |
Indivior PLCINDV | 3 | Buy | $48.00 | +37.14% | Maintains | 22 days ago |
Heron Therapeutics IncHRTX | 3 | Buy | $6.00 | +334.78% | Reiterates | 25 days ago |
Xeris Biopharma Holdings IncXERS | 4 | Buy | $10.00 | +35.87% | Reiterates | 25 days ago |
Collegium Pharmaceutical IncCOLL | 6 | Buy | $60.00 | +27.36% | Reiterates | 25 days ago |
Enanta Pharmaceuticals IncENTA | 2 | Buy | $20.00 | +51.63% | Reiterates | 25 days ago |
Trevi Therapeutics IncTRVI | 3 | Buy | $21.00 | +91.61% | Reiterates | 25 days ago |
Rani Therapeutics Holdings IncRANI | 4 | Buy | $11.00 | +816.67% | Reiterates | 25 days ago |
Eupraxia Pharmaceuticals IncEPRX | 4 | Buy | $12.00 | +33.33% | Reiterates | 25 days ago |
Omeros CorpOMER | 3 | Buy | $40.00 | +241.30% | Maintains | a month ago |
Milestone Pharmaceuticals IncMIST | 4 | Buy | $8.00 | +308.16% | Reiterates | a month ago |
Pelthos Therapeutics IncPTHS | 1 | Buy | $60.00 | +137.15% | Initiates Coverage On | 2 months ago |
Traws Pharma IncTRAW | 1 | Buy | $8.00 | +292.16% | Initiates Coverage On | 2 months ago |
Cardiol Therapeutics IncCRDL | 2 | Buy | $9.00 | +836.52% | Reiterates | 2 months ago |
Genfit SaGNFTY | 2 | Buy | $7.00 | +44.33% | Maintains | 4 months ago |
Rein Therapeutics IncRNTX | 1 | Buy | $10.00 | +675.19% | Initiates Coverage On | 4 months ago |
Ani Pharmaceuticals IncANIP | 5 | Buy | $121.00 | +51.25% | Maintains | 5 months ago |
Valneva SeVALN | 2 | Buy | $18.00 | +96.72% | Reiterates | 5 months ago |
Journey Medical CorpDERM | 2 | Buy | $13.00 | +51.34% | Initiates Coverage On | 5 months ago |
Achieve Life Sciences IncACHV | 2 | Buy | $12.00 | +179.07% | Initiates Coverage On | 5 months ago |
Polypid LtdPYPD | 4 | Buy | $13.00 | +166.94% | Reiterates | 6 months ago |
Connect Biopharma Holdings LtdCNTB | 2 | Buy | $7.00 | +184.55% | Reiterates | 6 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $29.00 | +365.49% | Assumes | 6 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $26.00 | +177.78% | Initiates Coverage On | 7 months ago |
Rockwell Medical IncRMTI | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Adial Pharmaceuticals IncADIL | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Emergent Biosolutions IncEBS | 4 | Strong Buy | $16.00 | N/A | Reiterates | a year ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $455.00 | N/A | Initiates Coverage On | 2 years ago |
Sanara Medtech IncSMTI | 4 | Strong Buy | $59.00 | N/A | Reiterates | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $180.00 | N/A | Reiterates | 2 years ago |
Elutia IncELUT | 3 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Amryt Pharma PLCAMYT | 2 | Hold | $14.75 | N/A | Downgrades | 3 years ago |
Veru IncVERU | 3 | Strong Buy | $220.00 | N/A | Maintains | 3 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Obseva SaOBSVF | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Alkermes PLCALKS | 1 | Strong Buy | $32.00 | N/A | Upgrades | 4 years ago |
IMV IncIMVIQ | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Redhill Biopharma LtdRDHL | 1 | Strong Buy | $22,000.00 | N/A | Initiates Coverage On | 4 years ago |
Trevena IncTRVN | 1 | Strong Buy | $3,125.00 | N/A | Initiates Coverage On | 5 years ago |
Optinose IncOPTN | 3 | Strong Buy | $315.00 | N/A | Reiterates | 6 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Hold | $46.00 | N/A | Maintains | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $30.00 | N/A | Reiterates | 6 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Strong Buy | $42.00 | N/A | Maintains | 7 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $50.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.